Ivision Tech SpA
Ivision Tech SpA has a fully diluted share count of 7,912,406 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Ivision Tech SpA, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data limits the ability to compare the company's performance against industry_config preferred metrics or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the risks associated with regional market exposure. Growth trajectory data is also limited. The outlook for the current and next fiscal years does not include numeric deltas or revenue history, making it difficult to evaluate the company's growth potential or historical performance. Risk factors includ
Business. Ivision Tech SpA (IVN.MI) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana. As specific segment and geographic breakdowns are not provided, the company is described at the industry level as a provider of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Ivision Tech SpA (IVN.MI) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana. As specific segment and geographic breakdowns are not provided, the company is described at the industry level as a provider of medical equipment and supplies.
Ivision Tech SpA has a fully diluted share count of 7,912,406 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and return metrics are not available for Ivision Tech SpA, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data limits the ability to compare the company's performance against industry_config preferred metrics or cohort medians.
The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the risks associated with regional market exposure.
Growth trajectory data is also limited. The outlook for the current and next fiscal years does not include numeric deltas or revenue history, making it difficult to evaluate the company's growth potential or historical performance.
Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuances that would affect shareholder value.
Recent events, such as filings or transcripts, are not available in the provided data, which limits the ability to analyze the company's strategic direction or operational developments in the near term.
- Ivision Tech SpA has no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities.
- Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
- Profitability and return metrics are not available, limiting the ability to compare the company's performance against industry benchmarks.
- Revenue concentration and geographic exposure are not disclosed, making it difficult to assess diversification and regional market risks.
- Growth trajectory data is limited, with no numeric deltas or revenue history provided for the current or next fiscal years.
- Recent events, such as filings or transcripts, are not available, limiting the ability to analyze the company's strategic direction or operational developments.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €7.9M, +238,7% YoY; Operating income +12 267,4% YoY.
- ▍Revenue €7.9M, +238,7% YoY
- ▍Operating income +12 267,4% YoY
- ▍Net income +269,0% YoY
- ▍Free cash flow +110,2% YoY
- ▍Net margin 3.6%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Ivision Tech SpA Market data — financials · 2026-05-28